Lucentis effective for proliferative diabetic retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Clinical Trials | Diabetes | Endocrinology | Health | Lucentis | National Institutes of Health (NIH) | Ranibizumab Injection